Promotion in the Clearance of Aggregated Aβ In Vivo Using Amyloid Selective Photo-Oxygenation Technology

Alzheimer’s disease (AD) is characterized by the aggregation and deposition of 2 amyloid proteins: amyloid β peptide (Aβ) and tau protein. Immunotherapies using anti-Aβ antibodies to promote the clearance of aggregated Aβ have recently been highlighted as a promising disease-modifying approach again...

Descripción completa

Detalles Bibliográficos
Autores principales: Hori, Yukiko, Sohma, Youhei, Kanai, Motomu, Tomita, Taisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523840/
https://www.ncbi.nlm.nih.gov/pubmed/36189373
http://dx.doi.org/10.1177/26331055221126179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523840/
https://www.ncbi.nlm.nih.gov/pubmed/36189373
http://dx.doi.org/10.1177/26331055221126179

Ejemplares similares